Cardiol Therapeut…
USUSDCardiol Therapeutics Inc Class A (US:CRDL) — Biotechnology: Biological Products (No Diagnostic Substances). Börside arv, kus ettevõtte aktsiatega kaubeldakse: 2. Sellel lehel — hind ja graafik, dividendid, suurimad aktsionärid ja aktsiate arvu ajalugu.
Ettevõtte Kohta
- Veebileht
- cardiolrx.com
- Investorite Suhted
- cardiolrx.com/investors/events-presentations/
- Sektor
- Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
- Peakontor
- OAKVILLE, Canada
- Tegevjuht
- David G. Elsley
- Töötajad
- 18
- Ringluses Olevad Aktsiad
- 121.51 mln seisuga 2025-12-31
- Vabalt Kaubeldavad Aktsiad
- 91.98 mln
- Turukapitalisatsioon
- 149.46 mln USD
- Siseringi Isikud
- 2.27%
- Institutsionaalsed Investorid
- 26.4%
- Tegevusala (SIC)
- Biological Products, (No Diagnostic Substances)
- P/E
- kahjum
- FCF
- −23.9 mln CAD
- Võlg
- ?
- Kasum ja FCF — 12 kuu jooksul kuni 31.12.2025 (ettevõtte viimane raport).
Kirjeldus
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38, a novel subcutaneously administered drug formulation of cannabidiol for the treatment of heart failure. Cardiol Therapeutics Inc. was incorporated in 2017 and is headquartered in Oakville, Canada.
Selle Nädala Uudised
Pressiteated ettevõtte investorite veebisaidilt, uuendatakse iga päev. Lingid viivad ettevõtte veebilehele. Pealkirjad on originaalkeeles, nagu ettevõtte veebilehel.
Suurimad Omanikud
| Omanik | Osalus | Aktsiad | Aruande Kuupäev |
|---|---|---|---|
| MMCAP International, Inc… | 13.12% | 15.6 mln | 2026-06-30 |
| Tejara Capital Ltd | 4.3% | 5.11 mln | 2026-06-30 |
| Ikarian Capital, LLC | 2.8% | 3.33 mln | 2026-06-30 |
| Elsley (David) (Director… | ≈1.13% | 1.34 mln | 2025-10-17 |
| Boothbay Fund Management… | 0.82% | 975 721 | 2026-06-30 |
| Citadel Advisors Llc | 0.67% | 796 529 | 2026-06-30 |
| Renaissance Technologies… | 0.65% | 772 837 | 2026-06-30 |
| Two Sigma Investments, L… | 0.63% | 746 937 | 2026-06-30 |
| Hamer (Andrew Warwick M.… | ≈0.62% | 739 947 | 2026-08-28 |
| Integrity Alliance, Llc. | 0.33% | 388 492 | 2026-06-30 |
| Morgan Stanley | 0.3% | 355 030 | 2026-06-30 |
| Torreamione (Guilermo) (… | ≈0.28% | 334 309 | 2026-09-08 |
| Goldman Sachs Group Inc | 0.28% | 333 900 | 2026-06-30 |
| Chao (Jennifer M) (Direc… | ≈0.12% | 146 667 | 2026-08-21 |
| Loxam (Teri) (Director o… | ≈0.12% | 146 667 | 2026-08-21 |
| Fidelity Concord Street… | 0.05% | 60 663 | 2026-07-31 |
Logi Sisse Google